-
Campaign leadership spurs innovation and progress at Dana-Farber
Motivated by a desire to ease the burden of cancer for future patients, the leaders of The Dana-Farber Campaign have dedicated their time and leveraged their expertise and connections for the entirety of this ambitious, multi-year fundraising effort.
-
Sheer joy and “finding the fun”: DFMC runners defy cancer with $8.8 million raised
Dana-Farber Marathon Challenge runners raised $8.8 million in 2024 to benefit the Claudia Adams Barr Program in Innovative Basic Cancer Research, advancing promising ideas at their earliest stages so they can move forward toward discovery and cure.
-
Leukemia & Lymphoma Society grants target blood cancers
The Leukemia & Lymphoma Society recently awarded more than $7.3 million in grants to Dana-Farber researchers in its quest to better understand and find cures for blood cancers.
-
Susan G. Komen funds research into new breast cancer treatments
In its mission to eradicate breast cancer, Susan G. Komen has invested nearly $1.1 billion in research since its founding in 1982. In 2023, Komen continued a longstanding partnership with Dana-Farber by awarding $2.3 million in new grants to Dana-Farber faculty members.
-
Palumbo family moves needle for patients with rare pediatric cancers
On the cusp of Chad Palumbo’s senior year of high school in 2022, he found himself in an unexpected place: Dana-Farber Cancer Institute. Chad had been diagnosed with rhabdomyosarcoma, a rare form of soft tissue cancer that appears mainly in children and teens.
-
High-risk, high-reward research is The Mathers Foundation’s priority
Transformative basic research is the focus of The G. Harold and Leila Y. Mathers Charitable Foundation, which recently awarded $1.5 million to fund Dana-Farber research on unraveling the inner workings of human cells.
-
Grants catalyze new advances in prostate cancer
The Prostate Cancer Foundation has awarded $1.45 million in grants to three Dana-Farber investigators researching more powerful treatments for the disease.
-
The Ambrose Monell Foundation fuels critical immunotherapy priorities
By encouraging strategic risk-taking and rewarding experimentation and new ideas, the Ambrose Monell Foundation is empowering Dana-Farber to capitalize on its collective expertise to develop a new generation of innovative cancer-fighting immunotherapies tailored to the specific needs of patients.
-
Stop & Shop establishes Therapeutic Food Pantry
To help combat food insecurity among cancer patients, Stop & Shop made a $1 million gift to establish the Dana-Farber Cancer Institute Therapeutic Food Pantry, an equity-driven, cross-sector partnership to eliminate barriers that disrupt access to food and impact social determinants of health.
-
Visionary donors aim to make early detection more comprehensive and accessible
Peggy and Greg Strakosch are visionaries whose recent gift will empower Dana-Farber to take the next step in producing a blood test that can identify patients most at risk for developing a BRCA-related cancers.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.